United Therapeutics (UTHR) Misses Q4 EPS by 21c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $489.41 -1.64%
EPS Growth %: -10.1%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -10.1%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.51, $0.21 worse than the analyst estimate of $3.72. Revenue for the quarter came in at $415.2 million versus the consensus estimate of $427.62 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- KB Home (KBH) PT Lowered to $50 at RBC Capital
- Espey Manufacturing (ESP) Tops Q4 EPS by 24c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
